Apimeds Pharmaceuticals U... (APUS)
NYSE: APUS
· Real-Time Price · USD
2.11
0.17 (8.76%)
At close: Sep 12, 2025, 3:59 PM
2.04
-3.32%
After-hours: Sep 12, 2025, 07:36 PM EDT
Apimeds Pharmaceuticals US Inc Revenue
Apimeds Pharmaceuticals US Inc reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Apimeds Pharmaceuticals US Inc generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
2
Market Cap
26.52M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |